Events at the DeWitt Wallace Institute

Neuromodulation is the use of medications or technology to alter the activity of neurons with the goal of reducing symptoms, improving functioning, and improving quality of life. Over the past year, there have been some changes to the neuromodulation program at Weill Cornell Medicine and NewYork–Presbyterian. Dr. Dennis Popeo will discuss uses for electroconvulsive therapy beyond mood disorders. Dr. Roy Smetana will discuss ketamine treatment. Dr. Benjamin Zebley will discuss TMS. After the presentations, the three presenters will field questions from the audience about access to these services and other topics of interest regarding neuromodulation.

More Event Information

“The Analyst’s Self as Instrument: Asset or Liability or Both?” Elizabeth Lunbeck, Ph.D., Harvard University

“Madness and Enterprise: Psychiatry, Economic Reason, and the Emergence of Pathological Value” Nima Bassiri, Ph.D., Duke University

“Type and Character” Merve Emre, Ph.D., Wesleyan University

Heino Meyer-Bahlburg, Ph.D., Columbia University

Bhrigupati Singh, Ph.D., Brown University

Michal Shapira, Ph.D.

Adam Shatz in conversation with Ben Kafka, Ph.D., L.P.

Patrick Weil, Ph.D.

Alexandra Bacopoulos-Viau, Ph.D. DeWitt Wallace Institute of Psychiatry